Combined Blockade of Smad3 and JNK Pathways Ameliorates Progressive Fibrosis in Folic Acid Nephropathy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combined Blockade of Smad3 and JNK Pathways Ameliorates Progressive Fibrosis in Folic Acid Nephropathy
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-08-09
DOI
10.3389/fphar.2019.00880
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progression of Chronic Kidney Disease After Acute Kidney InjuryNovelty and Significance
- (2016) Maria Picken et al. HYPERTENSION
- Linking acute kidney injury to chronic kidney disease: the missing links
- (2016) Mohammed A. Kaballo et al. JOURNAL OF NEPHROLOGY
- The inflammatory cytokine TWEAK decreases PGC-1α expression and mitochondrial function in acute kidney injury
- (2016) Olga Ruiz-Andres et al. KIDNEY INTERNATIONAL
- Mitochondria in Acute Kidney Injury
- (2016) Kenneth M. Ralto et al. SEMINARS IN NEPHROLOGY
- Smad3 deficiency protects mice from obesity-induced podocyte injury that precedes insulin resistance
- (2015) Yu B.Y. Sun et al. KIDNEY INTERNATIONAL
- An Inducible Lentiviral Guide RNA Platform Enables the Identification of Tumor-Essential Genes and Tumor-Promoting Mutations In Vivo
- (2015) Brandon J. Aubrey et al. Cell Reports
- Smad3/Nox4-mediated mitochondrial dysfunction plays a crucial role in puromycin aminonucleoside-induced podocyte damage
- (2014) Lixia Yu et al. CELLULAR SIGNALLING
- Mitochondria-targeted therapies for acute kidney injury
- (2014) Luis Carlos Tábara et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Accelerated recovery of renal mitochondrial and tubule homeostasis with SIRT1/PGC-1α activation following ischemia–reperfusion injury
- (2013) Jason A. Funk et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation
- (2012) Xinli Qu et al. JOURNAL OF PATHOLOGY
- Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury
- (2012) Yanggang Yuan et al. KIDNEY INTERNATIONAL
- Protection from Obesity and Diabetes by Blockade of TGF-β/Smad3 Signaling
- (2011) Hariom Yadav et al. Cell Metabolism
- Smad3 Deficiency in Mice Protects Against Insulin Resistance and Obesity Induced by a High-Fat Diet
- (2011) C. K. Tan et al. DIABETES
- Inhibition of c-Jun-N-terminal Kinase Increases Cardiac Peroxisome Proliferator-activated Receptor α Expression and Fatty Acid Oxidation and Prevents Lipopolysaccharide-induced Heart Dysfunction
- (2011) Konstantinos Drosatos et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice
- (2011) Mei Tran et al. JOURNAL OF CLINICAL INVESTIGATION
- IHG-1 Promotes Mitochondrial Biogenesis by Stabilizing PGC-1
- (2011) F. B. Hickey et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Resveratrol Inhibits Renal Fibrosis in the Obstructed Kidney
- (2010) Jinhua Li et al. AMERICAN JOURNAL OF PATHOLOGY
- Blockade of Endothelial-Mesenchymal Transition by a Smad3 Inhibitor Delays the Early Development of Streptozotocin-Induced Diabetic Nephropathy
- (2010) J. Li et al. DIABETES
- Down-expression of PGC-1α partially mediated by JNK/c-Jun through binding to CRE site during apoptotic procedure in cerebellar granule neurons
- (2010) Jingyao Liang et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Regulation of Dedifferentiation and Redifferentiation in Renal Proximal Tubular Cells by the Epidermal Growth Factor Receptor
- (2008) M. A. Hallman et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More